Open a Pharma Book to Open the Possibilities
The pharmaceutical industry moves at a pace that is lightning fast – especially with the escalating popularity of the Internet of Things (IoT), artificial intelligence (AI), and digital tech. Some of the most powerful, in-depth, and revolutionary ideas are often shared in a format that is less technologically advanced, however: books.
There is much to learn from the most popular new books out for the biopharmaceutical industry, and if you’re interested in honing your skills and expanding your mindset in all things pharma but aren’t sure where to start, here are five of the best pharma books you can buy on Amazon right now:
Eric Topol is one of the top doctors in the United States; in this book, he explains how artificial intelligence will help revolutionize patient care and empower physicians. Going in-depth about how the relationship between doctors and patients today has become broken, he pinpoints significant healthcare challenges from doctors being overwhelmed and distracted, unable to really connect with their patients, to medical errors and incorrect diagnoses on the rise at alarming rates. Topol states that AI has the ability to transform everything doctors are responsible for, from taking notes to delivering treatment. Pick up this to seller for just under $20.00 on Amazon.
Enjoy this bestseller as an updated edition from Amazon, complete with bonus material like a new foreword and afterword with new research included. Whitaker is an award-winning history and science writer and in this pharma book, he looks into why the number of disabled and mentally ill people in the U.S. has more than tripled over the past 20 years. This epidemic is spreading most rapidly amongst our children. This title challenges readers to think through that question as Whitaker investigates what we know about the causes of disorders. Readers will be shocked to discover what was reported in the scientific journals that explore whether medications “fix” chemical imbalances in the brain – or create them. Don’t wait to pick up your copy on Amazon from $0.00 for an audiobook, $13.99 on Kindle, $9.99 for paperback, or $37.71 for a hardcover copy.
This New York Times bestseller is also winner of the Financial Times/McKinsey Business Book of the Year Award for 2018. Get the inside story of the rise and fall of Theranos, the multibillion-dollar biotech startup. John Carreyrou is a prize-winning journalist who recounts the story of the biggest corporate fraud case since Enron. Theranos founder Elizabeth Holmes was a brilliant Stanford dropout whose startup promised to revolutionize the medical industry by way of a machine that could make blood testing faster and easier. Theranos sold shares that valued the company at more than $9 billion, but there was one problem: the machine didn’t actually work. This tale is set to be adapted into a film starring Jennifer Lawrence; don’t miss the chance to get the scoop before the movie hits theaters – find it on Amazon today.
The Academy of Communication in Healthcare has worked with health systems to teach communication skills that put relationships at the center of care, from pharma reps and physicians to patients and other healthcare providers. Research shows that communication is the number one factor that impacts the patient experience more than anything else. This book will teach you communication skills you’ll need to boost patient adherence, make fewer errors, increase patient satisfaction and build teamwork with providers, and more. Read up on the best way to hone your skills in sections that cover shared decision-making, feedback, teamwork, coaching, diversity, and more. The book also outlines a proven blueprint for more effective communication across the entire healthcare industry. Pick up your copy on Amazon as an audiobook for free, a Kindle edition for $17.60, or as a hardcover for $25.49 today.
This book is a must-have for anyone who is a biotech deal maker, investor, adviser, entrepreneur, or executive – really, for anyone who needs to build and analyze forecasts and valuations of R&D-stage drugs. Praised as invaluable, detailed, well-validated, and a helpful insight, this pharma book serves as a guide to building a valuation model for biotech products or portfolios. It’s the perfect companion for those who are making investment decisions, pitching to potential funders or partners, or assessing their R&D program. Learn the inputs that go into modeling, how to forecast better, and how it all ties together. Take advantage of over 150 current references from peer-reviewed research, SEC filings, and industry white papers; vetted benchmarks for key drivers of expenses, valuation, and income; and proprietary analyses by Pharmagellan’s experienced consulting team with this must-have guide available on Amazon in paperback.
In addition to the above five pharma books, you may also be interested in Drugs: From Discovery to Approval, The BioTech Primer, or New Drugs: An Insider’s Guide to the FDA’s New Drug Approval Process. With literally hundreds of pharma books available that cover everything from histories in the industry to applying new and effective skills and technology to your everyday pharmaceutical career, you’re sure to find a book that will get your mind going and re-ignite your passion for the industry. You can also stay in the loop on all the latest pharmaceutical industry trends by attending pharma conferences as often as you can – be sure to bring your new books from Amazon with you when you go.